Stock listing
Oneness Biotech Co., Ltd.
Selected listing: ONES · LUXSE · USD · LU
Oneness Biotech Co., Ltd. (LUXSE:ONES), Health Technology. Latest release Jul 4, 2022: Oneness Biotech : The Drug Administration of Vietnam has accepted…
- Ticker
- LUXSE:ONES
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LUXSE
- Currency
- USD
Latest news from Oneness Biotech Co., Ltd.
Oneness Biotech : The Drug Administration of Vietnam has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon
July 4, 2022
Oneness Biotech : announces the information about the investor's conference of 2022 Q2.
June 22, 2022
Oneness Biotech : The findings of the MoA studies on Fespixon(ON101) under collaboration with TMU and NYCU have been accepted and published by a renown SCI journal, JID Innovations
June 2, 2022
Oneness Biotech : receives a China patent on antagonistic PDL1 aptamers.
May 26, 2022
Oneness Biotech : The Annual General Shareholders' Meeting approved the removal of non-competition restriction on the newly-elected director.
May 24, 2022
Research Oneness Biotech Co., Ltd.
Oneness Biotech Co., Ltd. company profile
View the public company page for Oneness Biotech Co., Ltd. on 6ix.
Oneness Biotech Co., Ltd. news
Read company news and market updates connected to Oneness Biotech Co., Ltd..
Oneness Biotech Co., Ltd. investor events
Find investor webinars, events, and replay context for Oneness Biotech Co., Ltd..